Dr Neda Haghighi

Dr Neda Haghighi is an experienced Radiation Oncologist specialising in the management and treatment of brain and spinal (CNS) tumors. She is currently practicing at Icon Cancer Centre Richmond and Icon Cancer Centre Holmesglen in Melbourne, Victoria, Australia.

Dr Haghighi possesses extensive expertise in the field and has completed an extended fellowship in intracranial and extracranial stereotactic radiation therapy, further enhancing her knowledge and skills. Her primary interests lie in the treatment of CNS-related malignancies, particularly brain and spinal tumors, as well as oligometastatic disease.

With a strong commitment to clinical research, Dr Haghighi actively participates in various clinical trials related to CNS conditions at Icon Cancer Centre and Peter MacCallum Cancer Centre. She serves as a primary investigator, co-investigator, and trial management committee member for these trials. Her involvement in research contributes to further advancements in the field of radiation oncology.

Dr Haghighi is an esteemed member of professional organizations such as the Trans Tasmanian Radiation Oncology Group (TROG), Cooperative Trials Group for Neuro-Oncology (COGNO), and International Society of Radiosurgery (ISRS). She also holds committee positions in several CNS-related interest groups, allowing her to actively contribute to the development and dissemination of knowledge in her field.

In addition to her specializations, Dr Haghighi has a particular interest in radiosurgery for the treatment of benign base of skull conditions and functional neurological disorders. She has authored journal articles focused on stereotactic radiotherapy and has been invited to speak at conferences and meetings addressing intracranial conditions and radiosurgery. Furthermore, she has contributed to the development of departmental protocols relating to the treatment of benign and malignant conditions using stereotactic radiation therapy.

Dr Neda Haghighi is a dedicated and accomplished radiation oncologist, continuously striving for excellence in patient care and seeking innovative approaches to improving outcomes in the treatment of brain and spinal tumors.